SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2022

SEGMENT REPORTING

Schedule of revenue by reportable segments

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Net Revenues
Generics, Established Brands, and Other	$	71,219	$	52,061	$	198,057	$	155,207
Rare Disease		12,602		—		24,096		—
Total net revenues	$	83,821	$	52,061	$	222,153	$	155,207
Segment earnings/(loss) before interest, taxes, depreciation and amortization (“EBITDA”) and reconciliation to (loss)/income before income taxes
Generics, Established Brands, and Other		22,099		17,030		52,103		53,529
Rare Disease		(2,382)		(3,085)		(19,493)		(8,836)
Depreciation and amortization		(14,167)		(11,346)		(42,488)		(33,568)
Corporate and other unallocated expenses(1)		(10,545)		(6,161)		(27,225)		(27,195)
Total operating loss	$	(4,995)	$	(3,562)	$	(37,103)	$	(16,070)
Interest expense, net		(7,264)		(2,497)		(20,546)		(7,482)
Other income/(expense), net		37		(1,071)		712		(1,653)
Loss before benefit for income taxes	$	(12,222)	$	(7,130)	$	(56,937)	$	(25,205)

(1) Includes expenses not directly allocated or attributable to a reporting segment, including certain management, legal, accounting, human resources, insurance, and information technology expenses, and are included in selling, general, and administrative expenses in our unaudited interim consolidated statement of operations.

Schedule of revenue by geographic operations

(in thousands)	Three Months Ended September 30,				Nine Months Ended September 30,
Location of Operations	2022		2021		2022		2021
United States	$	82,851	$	51,100	$	219,422	$	152,007
Canada		970		961		2,731		3,200
Total Revenue	$	83,821	$	52,061	$	222,153	$	155,207

Schedule of property and equipment by geographic location

(in thousands)	September 30, 2022		December 31, 2021
United States	$	38,932	$	38,564
Canada(1)		3,328		13,831
India		570		276
Total property and equipment, net	$	42,830	$	52,671

(1) Amounts as of September 30, 2022 exclude the land and building at our Canada facility, which are classified as held for sale as of September 30, 2022. These assets have a carrying value of $8.0 million.